alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2013055EN.01001103.xml

| 23.2.2013 | EN | Official Journal of the European Union | C 55/11 |
| --- | --- | --- | --- |

23.2.2013

EN

Official Journal of the European Union

C 55/11

---

Judgment of the General Court of 16 January 2013 — Spectrum Brands (UK) v OHIM — Philips (STEAM GLIDE)

(Case T-544/11) (1)

1

(Community trade mark - Invalidity proceedings - Community word mark STEAM GLIDE - Absolute ground for refusal - Descriptive character - Article 7(1)(c) of Regulation (EC) No 207/2009)

2013/C 55/19

Language of the case: English

Parties

Parties

Applicant: Spectrum Brands (UK) Ltd (Manchester, United Kingdom) (represented by: S. Malynicz, Barrister)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented initially by: D. Botis, subsequently by G. Schneider and, finally, by G. Schneider and A. Folliard-Monguiral, Agents)

Defendant:

Other party to the proceedings intervening before the Board of Appeal of OHIM: Koninklijke Philips Electronics NV (Eindhoven, Netherlands) (represented by: L. Alonso Domingo, lawyer)

Other party to the proceedings intervening before the Board of Appeal of OHIM:

Re:

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 14 July 2011 (Case R 1289/2010-1), concerning invalidity proceedings between Koninklijke Philips Electronics NV and Spectrum Brands (UK) Ltd.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Spectrum Brands (UK) Ltd to pay, in addition to its own costs, the costs incurred by the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) and by Koninklijke Philips Electronics NV. |
| --- | --- |

2.

Orders Spectrum Brands (UK) Ltd to pay, in addition to its own costs, the costs incurred by the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) and by Koninklijke Philips Electronics NV.

---

(1)  OJ C 6, 7.1.2012.

1

---
```

[Federal Register Volume 76, Number 177 (Tuesday, September 13, 2011)]
[Notices]
[Page 56491]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-23532]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 7582]

Culturally Significant Objects Imported for Exhibition 
Determinations: ``Tombs, Temples and Warriors: China's Imperial 
Legacy''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, and Delegation of Authority No. 
236-3 of August 28, 2000 (and, as appropriate, Delegation of Authority 
No. 257 of April 15, 2003), I hereby determine that the objects to be 
included in the exhibition ``Tombs, Temples and Warriors: China's 
Imperial Legacy,'' imported from abroad for temporary exhibition within 
the United States, are of cultural significance. The objects are 
imported pursuant to a loan agreement with the foreign owner or 
custodian. I also determine that the exhibition or display of the 
exhibit objects at the Bowers Museum, Santa Ana, California, from on or 
about October 1, 2011, until on or about March 4, 2012, at the Houston 
Museum of Natural Sciences, Houston, Texas, from on or about April 1, 
2012 until on or about September 3, 2012, and at possible additional 
exhibitions or venues yet to be determined, is in the national 
interest. I have ordered that Public Notice of these Determinations be 
published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the exhibit objects, contact Kevin M. Gleeson, Attorney-
Adviser, Office of the Legal Adviser, U.S. Department of State 
(telephone: 571-345-3006). The mailing address is U.S. Department of 
State, SA-5, L/PD, Fifth Floor (Suite 5H03), Washington, DC 20522-0505.

    Dated: September 7, 2011.
Lee Satterfield,
Principal Deputy Assistant Secretary, Acting Bureau of Educational and 
Cultural Affairs, Department of State.
[FR Doc. 2011-23532 Filed 9-12-11; 8:45 am]
BILLING CODE 4710-05-P
```
# C_2014052EN.01001802.xml

| 22.2.2014 | EN | Official Journal of the European Union | C 52/18 |
| --- | --- | --- | --- |

22.2.2014

EN

Official Journal of the European Union

C 52/18

---

Judgment of the Court (Third Chamber) of 12 December 2013 (request for a preliminary ruling from the High Court of Justice (Chancery Division) — United Kingdom) — Actavis Group PTC EHF, Actavis UK Ltd v Sanofi

(Case C-443/12) (1)

1

(Medicinal products for human use - Supplementary protection certificate - Regulation (EC) No 469/2009 - Article 3 - Conditions for obtaining such a certificate - Successive marketing of two medicinal products containing, wholly or partially, the same active ingredient - Combination of active ingredients, one of which has already been marketed in the form of a medicinal product with a single active ingredient - Whether it is possible to obtain a number of certificates on the basis of the same patent and two marketing authorisations)

2014/C 52/30

Language of the case: English

Referring court

Referring court

High Court of Justice (Chancery Division)

Parties to the main proceedings

Parties to the main proceedings

Applicants: Actavis Group PTC EHF, Actavis UK Ltd

Applicants:

Defendant: Sanofi

Defendant:

Intervening party: Sanofi Pharma Bristol-Myers Squibb SNC

Intervening party:

Re:

Re:

Request for a preliminary ruling — High Court of Justice (Chancery Division) — Interpretation of Article 3(a) and (c) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (OJ 2009 L 152, p. 1) — Conditions for obtaining a supplementary protection certificate — Concept of ‘product protected by a basic patent in force’ — Criteria — Possibility of granting the certificate for each medicinal product where there is a patent covering a number of medicinal products.

Operative part of the judgment

Operative part of the judgment

In circumstances such as those in the main proceedings, where, on the basis of a patent protecting an innovative active ingredient and a marketing authorisation for a medicinal product containing that ingredient as the single active ingredient, the holder of that patent has already obtained a supplementary protection certificate for that active ingredient entitling him to oppose the use of that active ingredient, either alone or in combination with other active ingredients, Article 3(c) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products must be interpreted as precluding that patent holder from obtaining — on the basis of that same patent but a subsequent marketing authorisation for a different medicinal product containing that active ingredient in conjunction with another active ingredient which is not protected as such by the patent — a second supplementary protection certificate relating to that combination of active ingredients.

---

(1)  OJ C 389, 15.12.2012.

1

---
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2131 Referred in Senate (RFS)]

111th CONGRESS
  1st Session
                                H. R. 2131

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 24, 2009

Received; read twice and referred to the Committee on Foreign Relations

_______________________________________________________________________

                                 AN ACT

 
 To amend the Foreign Affairs Reform and Restructuring Act of 1998 to 
 reauthorize the United States Advisory Commission on Public Diplomacy.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REAUTHORIZATION OF UNITED STATES ADVISORY COMMISSION ON 
              PUBLIC DIPLOMACY.

    Section 1334 of the Foreign Affairs Reform and Restructuring Act of 
1998 (22 U.S.C. 6553) is amended by striking ``October 1, 2009'' and 
inserting ``October 1, 2010''.

            Passed the House of Representatives September 23, 2009.

            Attest:

                                            LORRAINE C. MILLER,

                                                                 Clerk.
```
Editorial Note on Part 160
Editorial Note: Nomenclature changes to part 160 appear by USCG-2012-0832, 77 FR 59785, 59786, Oct. 1, 2012.

§ 160.024-1 Incorporation by reference. ( a ) The following is incorporated by reference into this subpart: ( 1 ) “The Universal Color Language” and “The Color Names Dictionary” in *Color: Universal Language and Dictionary of Names,* National Bureau of Standards Special Publication 440, Dictionary 1976.
( b ) NBS Special Publication 440 may be obtained by ordering from the Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402 (Order by SD Catalog No. C13.10:440).
( c ) Approval to incorporate by reference the publication listed in this section was obtained from the Director of the Federal Register on November 1, 1979. The publication is on file at the Federal Register Library.
#### § 184.410 Electronic position fixing devices.

A vessel on an oceans route must be equipped with an electronic position fixing device, capable of providing accurate fixes for the area in which the vessel operates, to the satisfaction of the cognizant OCMI.

[CGD 85-080, 61 FR 1002, Jan. 10, 1996, as amended at 62 FR 51358, Sept. 30, 1997]
##### 



1.
    
    I have reviewed this report on Form 10-QSB of Central Federal Corporation;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the small business issuer as of, and for, the
periods presented in this report;4.
    
    The small business issuers other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:
 a)
    
    Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the small business issuer, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;b)
    
    Evaluated the effectiveness of the small business issuers disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; andc)
    
    Disclosed in this report any change in the small business issuers
internal control over financial reporting that occurred during the small business
issuers most recent fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the small business issuers internal control over
financial reporting; and
 5.
    
    The small business issuers other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the small business
issuers auditors and the audit committee of small business issuers board of directors:
 a)
    
    All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably likely
to adversely affect the small business issuers ability to record, process,
summarize and report financial information; andb)
    
    Any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuers internal
control over financial reporting.
 Date: May 12, 2006
    
    /s/ Mark S. AllioMark S. AllioChairman of the Board, Presidentand Chief Executive Officer
#### The First National Bank of Helena, Montana Territory, *v.*James K. O. Sherwood.

Judgment affirmed, with costs.. Opinion by

Hykman, J.
#### § 201.2 Mailing address; hours.

Documents required to be filed in, and correspondence relating to, proceedings governed by the regulations in this part should be addressed to “Secretary, Maritime Administration, Department of Transportation, Washington, DC 20590.” The Office of the Secretary, Maritime Administration, including the public document reading room, located in room 7210, 400 Seventh Street, SW., Washington, DC 20590, is open from 8:30 a.m. to 5:00 p.m.

[55 FR 12358, Apr. 3, 1990, as amended at 63 FR 9157, Feb. 24, 1998]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
      ( print page 26408)    
*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; Blending Research and Practice.                    

*Date:*                         May 18, 2007.                    

*Time:*                         11 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Kristen V. Huntley, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-8401, 301-435-1433,                         *huntleyk@mail.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: May 2, 2007.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-2286 Filed 5-8-07; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


We consent to the incorporation by reference in the Highlands Bankshares, Inc.
registration statement on Form S-3D (Registration No. 333-83618) of our report
dated January 24, 2003 on our audits of the consolidated financial statements of
Highlands Bankshares, Inc. as of December 31, 2002, 2001 and 2000, and for the
periods then ended. Such report is included in the Highlands Bankshares, Inc.
2002 Annual Report to Stockholders, which is filed as exhibit 13 to Form 10-K
for the year ended December 31, 2002.


                                         /s/ Brown, Edwards & Company, L.L.P.



Bristol, Virginia
March 28, 2003
---

---

# EXHIBIT 13.1

Certification Required by Rule
13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 (as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002)

I, Zvika Naggan, as Chief Executive
Officer of Cimatron Ltd. (the Company), certify, pursuant to 18 U.S.C. §
1350 (as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002), that, to my
knowledge:

(1)
          The accompanying annual report on Form 20-F of the Company for the fiscal year
          ended December 31, 2004, filed with the U.S. Securities and Exchange Commission
          (the Report), fully complies with the requirements of section 13(a)
          or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)
          The information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.

/s/ Zvika Naggan
_____________________
Zvika Naggan
Chief Executive Officer
June 30, 2005



---

---
§ 189.05-15 Posting. ( a ) The permit shall be carried in a manner similar to that described in § 189.01-5 for a certificate of inspection.
§ 183.432 Emergency lighting. ( a ) Each vessel must have adequate emergency lighting fitted along the line of escape to the main deck from all passenger and crew accommodation spaces located below the main deck.
( b ) The emergency lighting required by paragraph (a) of this section must automatically actuate upon failure of the main lighting system. If a vessel is not equipped with a single source of power for emergency lighting, it must have individual battery powered lights that: ( 1 ) Are automatically actuated upon loss of normal power;
( 2 ) Are not readily portable;
( 3 ) Are connected to an automatic battery charger; and
( 4 ) Have sufficient capacity for a minimum of 2 hours of continuous operation.
[CGD 85-080, 61 FR 997, Jan. 10, 1996, as amended at 62 FR 51358, Sept. 30, 1997]
#### § 221.93 Collection of civil penalties.

Within 30 days after receipt of the Hearing Officer's decision, or a decision on appeal, the Party must submit payment of any assessed penalty in the manner specified in the decision letter. Failure to make timely payment will result in the institution of appropriate action to collect the penalty.
**Exhibit      11.1**

**Coffee      Holding Co., Inc.**

**Computation      of Per Share Earnings**

|                                                        |   | **Years                Ended October 31,** |          |
|-------------------------------------------------------------|--------|--------------------------------------------|---------------|
|                                                        |   | **2006**                                   |          | 2005 |   | 2004 |   |
| **Net                Income (Loss)**                        |   | **$**                                      | **700,082**   |   | $ | 1,185,135 |   | $ | 875,342 |   |
|                                                        |   |                                       |          |   |   |   |   |   |   |   |
| **BASIC                EARNINGS:**                          |   |                                       |          |   |   |   |   |   |   |   |
| **Weighted                average number of common**        |   |                                       |          |   |   |   |   |   |   |   |
| **Shares                outstanding**                       |   |                                       | **5,529,830** |   |   | 4,721,327 |   |   | 3,999,650 |   |
|                                                        |   |                                       |          |   |   |   |   |   |   |   |
| **Basic                earnings (loss) per common share**   |   | **$**                                      | **.13**       |   | $ | .25 |   | $ | .22 |   |
|                                                        |   |                                       |          |   |   |   |   |   |   |   |
| **DILUTED                EARNINGS:**                        |   |                                       |          |   |   |   |   |   |   |   |
| **Weighted                average number of common**        |   |                                       |          |   |   |   |   |   |   |   |
| **Shares                outstanding**                       |   |                                       | **5,529,830** |   |   | 4,721,327 |   |   | 3,999,650 |   |
| **Warrants                - common stock equivalents**      |   |                                       | **70,000**    |   |   | 55,430 |   |   | - |   |
|                                                        |   |                                       |          |   |   |   |   |   |   |   |
| **Weighted                average number of common**        |   |                                       |          |   |   |   |   |   |   |   |
| **Shares                outstanding - as adjusted**         |   |                                       | **5,599,830** |   |   | 4,776,757 |   |   | 3,999,650 |   |
|                                                        |   |                                       |          |   |   |   |   |   |   |   |
| **Diluted                earnings (loss) per common share** |   | **$**                                      | **.13**       |   | $ | .25 |   | $ | .22 |   |

----
### Michigan Supreme Court Lansing, Michigan

Marilyn Kelly, Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk February 24, 2009

d0217 

# Order

February 24, 2009

137247(16)

DAVID SHOPE, Plaintiff-Appellee,

v SC: 137247 COA: 284276 WCAC: 07-000039 A.D. TRANSPORT EXPRESS, INC., Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the motion for re consideration of this Court’s November 25, 2008 order is considered, and it is DENIED, because it doe s not appear that the order was entered erroneously.